Sun Pharma has become one of the world's most profitable generic drug makers over the past 30 years, with a net profit of Rs. 516.55 crore in fiscal 2013 making it India's largest pharmaceutical company by market value. An investment of Rs. 100,000 in Sun Pharma's 1994 IPO would have grown to around Rs. 3.3 crore by December 2012 and close to Rs. 4 crore with current stock prices, due to two stock splits in 2010 and 2012 that increased the number of shares.

1. Sun Pharma – Value
of Investing
- Raj Raisinghani

2. Some Facts!!
 The next Infosys | Creating long-term value—Sun
Pharmaceutical
 It’s only 30 years on that Sun Pharma is hitting its
stride, having become one of the world’s most
profitable generic drug makers.
 It’s only 30 years on that the firm is hitting its
stride, having become one of the world’s most
profitable generic drug makers—net profit for
fiscal 2013 stood at Rs.516.55 crore—and India’s
biggest pharma company by market value.
At Rs.1,21,811 crore, as of 6 December, Sun
Pharma’s market value is about three times that
of Dr. Reddy’s Laboratories Ltd, the next most
valuable Indian drug maker.

3. The IPO
 The company had 2 stock splits in
2010 where 1stock became 5 stocks
and in 2012 when 5 stocks became
10.
 The management of Sun Pharma
claims that the amount of Rs 100000
invested in its IPO in 1994 would have
cumulatively grown to about Rs 3.3
crores by December 2012 when stock
price was Rs 710. With current price
of Rs 848.55 it would be close to 4
crore rupees.